InnovAge stock gained 1.82 percent after strong fiscal results

Published on 10/04/2026 at 22:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

InnovAge stock closed at USD 8.96 on October 2, while fiscal 2026 revenue reached USD 989.7 million. Fiscal 2027 guidance targets up to USD 1.085 billion in revenue.

INNV, US45784A1043, Illustration mit AI erstellt.

InnovAge stock (ISIN US45784A1043) closed at USD 8.96 on Nasdaq on October 2, 2026, gaining 1.82 percent for the session. The company had already reported fiscal 2026 revenue of USD 989.7 million on September 8, 2026, while setting a revenue range of USD 1.05 billion to USD 1.085 billion for fiscal 2027.

Revenue reaches USD 989.7 million

According to Yahoo Finance on September 8, 2026, InnovAge generated USD 989.7 million in fiscal 2026 revenue, up 15.9 percent from USD 853.7 million in fiscal 2025. The result came from the company's PACE healthcare platform for predominantly dual-eligible seniors.

Profitability also improved on a GAAP basis. Fiscal 2026 net loss narrowed to USD 0.7 million from USD 35.3 million in fiscal 2025, while operating income reached USD 2.6 million compared with an operating loss of USD 29.8 million in the prior year.

Guidance points to further growth

The September 8, 2026 release set fiscal 2027 total revenue guidance at USD 1.05 billion to USD 1.085 billion and adjusted EBITDA guidance at USD 105 million to USD 115 million. The same release put fiscal 2026 adjusted EBITDA at USD 94.6 million, compared with USD 34.5 million in fiscal 2025.

That guidance implies a continued expansion from the latest reported year, but the quality of earnings remains important. Litigation costs and settlements totaled USD 57.0 million in fiscal 2026 and were included among the adjustments used in adjusted EBITDA, making the gap between GAAP earnings and adjusted performance material.

Stock remains below its yearly high

InnovAge served 8,230 participants across 20 centers in six states as of June 30, 2026. Fiscal 2027 guidance calls for an ending census of 8,625 to 8,850 participants, alongside total member months of 101,000 to 102,500.

The market snapshot puts the stock's 52-week range at USD 3.93 to USD 12.64 and market capitalization at USD 1.2 billion as of October 2, 2026. The closing price therefore remains USD 3.68 below the yearly high, while the fiscal outlook supplies the main operating benchmark for the shares.